Work

Whole‐Exome Sequencing for Diagnostic Investigation of 267 Patients From the Brazilian Public Health System ( SUS ) Followed by Reanalysis of Nondiagnostic Cases

Year: 2026
Type: article
Abstract: Although advances in genetic testing in recent years have improved patient care, especially regarding rare diseases, the path to molecular diagnosis remains lengthy for many patients in Brazil, particularly among families who rely exclusively on the public health system. Between 2017 and 2023, a total of 267 patients with suspected rare diseases were recruited from the Genetics Unit of the Instituto da Criança do Hospital das Clínicas da Universidade de São Paulo; blood samples from the probands and, when available, their parents were sent to Yokohama City University and submitted to whole-exome sequencing (WES). Among the 267 cases, 124 (46.4%) received molecular diagnostic findings; most of these patients had intellectual disability or developmental delay. In addition, 130 cases (48.6%) were classified as "no relevant variant identified" and another 13 cases (4.8%) were considered inconclusive; all underwent reanalysis of WES data, which led to a molecular diagnosis in 10 additional cases (7%) previously undetected, primarily through newly established gene-disease associations or updated interpretations of previously identified variants. Our diagnostic yield (46.4%) was consistent with those reported in large cohorts and meta-analysis published internationally. However, nondiagnostic results warrant further consideration and WES reanalysis should be considered as a strategy to improve diagnostic outcomes, even if mostly through periodic literature reviews and variant reinterpretation.
Language: English
Subfield: Genetics
Open Access status: hybrid
Estimated APC paid: $4,980
OpenAlex ID: W7237349490
FWCI:
Cites: 30
Cited by:
Related to: